137 related articles for article (PubMed ID: 7285326)
21. [Serum lipid-bound sialic acid as a marker in lung cancer patients].
Iwahashi N
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Dec; 28(12):1599-607. PubMed ID: 2077205
[TBL] [Abstract][Full Text] [Related]
22. Serum lipid-bound sialic acid as a tumoral marker in minimal residual tumors.
Musset M; Mathé G; Reizenstein P
Suppl J Med Oncol Tumor Pharmacother; 1988; 1():17-20. PubMed ID: 3249552
[No Abstract] [Full Text] [Related]
23. The significance of neopterin determination as a tumour marker in ovarian cancer.
Szarka G; Pulay T; Csömör S; Tran-Phoung-Mai ; Schumann B
Acta Chir Hung; 1988; 29(4):359-64. PubMed ID: 3239335
[TBL] [Abstract][Full Text] [Related]
24. Serum lipid-bound sialic acid as a tumoral marker in minimal residual tumors.
Musset M; Mathé G; Reizenstein P
Bull Soc Sci Med Grand Duche Luxemb; 1989; 126(1):17-20. PubMed ID: 2663215
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of serum sialic acid and carcinoembryonic antigen for the detection of early-stage colorectal cancer.
Tautu C; Pee D; Dunsmore M; Prorok JJ; Alhadeff JA
J Clin Lab Anal; 1991; 5(4):247-54. PubMed ID: 1890538
[TBL] [Abstract][Full Text] [Related]
26. Assessing benefits of combining biochemical and immunological markers in patients with lung carcinoma.
Patel PS; Raval GN; Rawal RR; Patel GH; Balar DB; Shah PM; Patel DD
Cancer Lett; 1994 Jul; 82(2):129-33. PubMed ID: 8050082
[TBL] [Abstract][Full Text] [Related]
27. [Circulating lipid-bound sialic acid levels in patients with malignant tumors].
Bassalyk LS; Novikov AM; Sokolova VD; Sorokin EN
Vopr Med Khim; 1984; 30(3):124-7. PubMed ID: 6474937
[TBL] [Abstract][Full Text] [Related]
28. [Biological markers in lung cancer].
Nikliński J; Furman M
Pneumonol Alergol Pol; 1991; 59(5-6):253-9. PubMed ID: 1668877
[No Abstract] [Full Text] [Related]
29. Utilization of determining lipid-bound sialic acid for the diagnosis and further prognosis of cancer.
Polívková J; Vosmiková K; Horák L
Neoplasma; 1992; 39(4):233-6. PubMed ID: 1436234
[TBL] [Abstract][Full Text] [Related]
30. Comparison between serum levels of carcinoembryonic antigen, sialic acid and phosphohexose isomerase in lung cancer.
Patel PS; Raval GN; Rawal RM; Patel GH; Balar DB; Shah PM; Patel DD
Neoplasma; 1995; 42(5):271-4. PubMed ID: 8552208
[TBL] [Abstract][Full Text] [Related]
31. Prevention of leukemia and the increase of plasma levels of lipid-bound sialic acid by allogeneic bone marrow transplantation in mice.
Wustrow TP; Katopodis N; Stock CC; Good RA
Cancer Res; 1985 Mar; 45(3):1097-100. PubMed ID: 3882223
[TBL] [Abstract][Full Text] [Related]
32. Multiple markers for lung cancer diagnosis: validation of models for advanced lung cancer.
Gail MH; Muenz L; McIntire KR; Radovich B; Braunstein G; Brown PR; Deftos L; Dnistrian A; Dunsmore M; Elashoff R
J Natl Cancer Inst; 1986 May; 76(5):805-16. PubMed ID: 2422426
[TBL] [Abstract][Full Text] [Related]
33. Serum protein-bound carbohydrates for following the course of disease in patients with metastatic breast carcinoma.
Waalkes TP; Mrochek JE; Dinsmore SR; Tormey DC
J Natl Cancer Inst; 1978 Sep; 61(3):703-7. PubMed ID: 278847
[TBL] [Abstract][Full Text] [Related]
34. Radioimmunoassay of carcinoembryonic antigen and clinical significance of its level in plasma.
Onizawa S; Watanabe S; Yagura T; Yasutomi M; Yamamura Y
Gan; 1976 Jun; 67(3):371-8. PubMed ID: 1001864
[TBL] [Abstract][Full Text] [Related]
35. Serum lipid-bound sialic acid as a marker in breast cancer.
Dnistrian AM; Schwartz MK; Katopodis N; Fracchia AA; Stock CC
Cancer; 1982 Nov; 50(9):1815-9. PubMed ID: 7116306
[TBL] [Abstract][Full Text] [Related]
36. Serum concentrations of lipid bound sialic acid and acute phase proteins in patients with cancer and nonmalignant disease.
Raynes JG
Biomed Pharmacother; 1983; 37(3):136-8. PubMed ID: 6605767
[TBL] [Abstract][Full Text] [Related]
37. The importance of polyamine determination in monitoring malignant gynaecological tumours.
Szarka G; Pulay T; Csömör S; Tran-Phuong-Mai ; Schumann B
Acta Chir Hung; 1988; 29(4):365-72. PubMed ID: 3239336
[TBL] [Abstract][Full Text] [Related]
38. [Lipid-bound sialic acids in the diagnosis of malignant neoplasms of the lungs and stomach].
Surina AG; Tokarskaia ZB
Lab Delo; 1986; (8):470-3. PubMed ID: 2429050
[No Abstract] [Full Text] [Related]
39. A re-evaluation of the lipid-bound sialic acid determination.
Végh Z; Kremmer T; Boldizsár M; Gesztesi KA; Szajáni B
Clin Chim Acta; 1991 Dec; 203(2-3):259-68. PubMed ID: 1777985
[TBL] [Abstract][Full Text] [Related]
40. Multiple markers for lung cancer diagnosis: validation of models for localized lung cancer.
Gail MH; Muenz L; McIntire KR; Radovich B; Braunstein G; Brown PR; Deftos L; Dnistrian A; Dunsmore M; Elashoff R
J Natl Cancer Inst; 1988 Mar; 80(2):97-101. PubMed ID: 3343691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
